| Dr Jason Michael West, DO | |
|
1615 Foxtrail Dr Ste 230, Loveland, CO 80538-9087 | |
| (970) 820-0470 | |
| (877) 720-0502 |
| Full Name | Dr Jason Michael West |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1615 Foxtrail Dr Ste 230, Loveland, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962634923 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 742 (Nebraska) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | DR0054557 (Colorado) | Primary |
| Entity Name | Bender Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215027107 PECOS PAC ID: 6204725575 Enrollment ID: O20040313000642 |
News Archive
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
A new Census Bureau report documents the alarming percentages of people in Texas and Florida without health insurance. Leaders of both states should hang their heads in shame because they have been among the most resistant in the nation to providing coverage for the uninsured under the Affordable Care Act, the law that Republicans deride as "Obamacare" (9/4).
Researchers are calling for improvements to the way early miscarriage is diagnosed following a new study published today in the BMJ.
Benitec Limited (ASX: BLT), (PINK:BNIKF), a world leader in expressed gene silencing for human therapeutics, is pleased to announce that the United States Patent and Trademark Office (USPTO) has today indicated that it is issuing the Re-examination Certificate, the formal final step in the USPTO's confirmation of patentability of claims in the key ‘099 Graham Patent [US Patent No. 6,573,099] "Genetic Constructs for Delaying or Repressing the Expression of a Target Gene", the wide-ranging platform technology patent covering the use of expressed RNA interference (RNAi) in human therapeutic applications.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jason Michael West, DO 1065 Ne 125th St Ste 409, North Miami, FL 33161-5834 Ph: (888) 852-6672 | Dr Jason Michael West, DO 1615 Foxtrail Dr Ste 230, Loveland, CO 80538-9087 Ph: (970) 820-0470 |
News Archive
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
A new Census Bureau report documents the alarming percentages of people in Texas and Florida without health insurance. Leaders of both states should hang their heads in shame because they have been among the most resistant in the nation to providing coverage for the uninsured under the Affordable Care Act, the law that Republicans deride as "Obamacare" (9/4).
Researchers are calling for improvements to the way early miscarriage is diagnosed following a new study published today in the BMJ.
Benitec Limited (ASX: BLT), (PINK:BNIKF), a world leader in expressed gene silencing for human therapeutics, is pleased to announce that the United States Patent and Trademark Office (USPTO) has today indicated that it is issuing the Re-examination Certificate, the formal final step in the USPTO's confirmation of patentability of claims in the key ‘099 Graham Patent [US Patent No. 6,573,099] "Genetic Constructs for Delaying or Repressing the Expression of a Target Gene", the wide-ranging platform technology patent covering the use of expressed RNA interference (RNAi) in human therapeutic applications.
› Verified 6 days ago
Aatif Mansoor, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2000 Boise Ave, Loveland, CO 80538 Phone: 970-820-4640 | |
Srinivas Bandi, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2923 Ginnala Dr, Loveland, CO 80538 Phone: 970-669-6660 Fax: 970-663-0721 | |
Eric J Straumanis, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1762 Hoffman Dr, Loveland, CO 80538 Phone: 970-663-3030 Fax: 970-663-3041 | |
Dr. Sheri J Friedman, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2695 Rocky Mountain Ave, Suite 200, Loveland, CO 80538 Phone: 970-667-7664 Fax: 970-622-9843 | |
Sonya S Wakil, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 221 E 29th St Ste 101, Loveland, CO 80538 Phone: 970-494-4200 | |
Jeffrey B Warren, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1615 Foxtrail Dr Ste 230, Loveland, CO 80538 Phone: 970-820-0470 Fax: 970-315-0030 | |
Dr. Lawrence A Meredith, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2695 Rocky Mountain Ave, Suite 200, Loveland, CO 80538 Phone: 970-667-7664 Fax: 970-622-9843 |